MDL | - |
---|---|
Molecular Weight | 748.90 |
Molecular Formula | C42H56N2O10 |
SMILES | O=C([C@H]1N(C([C@H](C2=CC(OC)=C(OC)C(OC)=C2)CC)=O)CCCC1)O[C@@H](C3=CC=CC(OCCN4CCOCC4)=C3)CCC5=CC=C(OC)C(OC)=C5 |
Shield-1 (Shld1) is a specific, cell-permeant and high-affinity ligand of FK506-binding protein-12 ( FKBP ), and reverses the instability by binding to mutated FKBP (mtFKBP) , allowing conditional expression of mtFKBP-fused proteins. Shield-1 can stabilize proteins tagged with a mutated FKBP12-derived destabilization domain (DD) [1] [2] [3] .
Shield-1 (0.1 nM-1 μM) responses characterization of destabilizing domains [1] . Shield-1 (1 μM; 24 h) treatment shows excellent expression on both TRPV5 and YFP when fused the mtFKBP destabilizing domain to either TRPV5 or YFP, and leads to mtFKBP-TRPV5 forming a functional ion channel [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Western Blot Analysis [1]
Cell Line: | NIH3T3 cells |
Concentration: | 0.1 nM-1 μM |
Incubation Time: | |
Result: | Stabilized the YFP fusion protein of L106P by higher concentrations of Shld1 (EC 50 ∼100 nM). |
Western Blot Analysis [2]
Cell Line: | HEK293 cells [2] |
Concentration: | 1 μM |
Incubation Time: | 24 hours |
Result: | Expressed both TRPV5 and YFP well when Shield-1 in the medium, whereas in the abscence of Shield-1 decreased TRPV5 or YFP protein expression. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 67.5 mg/mL ( 90.13 mM ; ultrasonic and warming and heat to 60°C)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.3353 mL | 6.6765 mL | 13.3529 mL |
5 mM | 0.2671 mL | 1.3353 mL | 2.6706 mL |
10 mM | 0.1335 mL | 0.6676 mL | 1.3353 mL |